Continental Advisors’s Labcorp LH Stock Holding History

Continental Advisors’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-29,100	Closed	-$2.54M	–	163
2014 Q3	$2.54M	Hold	29,100	–	–	0.58%	50
2014 Q2	$2.56M	Buy	+29,100	New	+$2.52M	0.6%	49

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Continental Advisors's LH Position: Q2 2017 in Review

Continental Advisors sold out of Labcorp (LH) in Q2 2017, closing a stake of 11,174 shares — an estimated $1.38M sold.

Continental Advisors first reported a position in LH in Q4 2013 and held it in 14 quarters. The position peaked at $6.72M in Q4 2014. 691 funds tracked by Wall St. Rank hold LH as of Q2 2017.

Continental Advisors reported no remaining Labcorp position as of Q2 2017 after selling out during the quarter.
Continental Advisors sold 11,174 Labcorp shares in Q2 2017, an estimated $1.38M.
Continental Advisors first reported a position in Labcorp in Q4 2013 and held it in 14 quarters.
Continental Advisors's Labcorp position peaked at $6.72M in Q4 2014.
691 funds tracked by Wall St. Rank held Labcorp as of Q2 2017.

Based on Continental Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.